Pre-Exposure Prophylaxis

"Pre-Exposure Prophylaxis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A method of disease prevention (abbreviated PrEP) which involves the administration of drugs to at-risk persons who have not been exposed to the disease-causing agent.

Descriptor ID	D065129
MeSH Number(s)	N02.421.726.758.655 N06.850.780.680.655
Concept/Terms	Pre-Exposure Prophylaxis Pre-Exposure Prophylaxis Pre Exposure Prophylaxis Pre-Exposure Prophylaxi Prophylaxi, Pre-Exposure Prophylaxis, Pre-Exposure Pre-Exposure Prophylaxis (PrEP) Pre Exposure Prophylaxis (PrEP) Pre-Exposure Prophylaxi (PrEP) Prophylaxi, Pre-Exposure (PrEP) Prophylaxis, Pre-Exposure (PrEP)

Below are MeSH descriptors whose meaning is more general than "Pre-Exposure Prophylaxis".

Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Preventive Health Services [N02.421.726]
Primary Prevention [N02.421.726.758]
Pre-Exposure Prophylaxis [N02.421.726.758.655]
Environment and Public Health [N06]
Public Health [N06.850]
Public Health Practice [N06.850.780]
Primary Prevention [N06.850.780.680]
Pre-Exposure Prophylaxis [N06.850.780.680.655]

Below are MeSH descriptors whose meaning is related to "Pre-Exposure Prophylaxis".

Below are MeSH descriptors whose meaning is more specific than "Pre-Exposure Prophylaxis".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pre-Exposure Prophylaxis" by people in this website by year, and whether "Pre-Exposure Prophylaxis" was a major or minor topic of these publications.

Bar chart showing 36 publications over 9 distinct years, with a maximum of 9 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2015	2	0	2
2016	1	0	1
2017	2	0	2
2018	3	1	4
2019	7	2	9
2020	4	4	8
2021	0	1	1
2022	8	0	8
2023	1	0	1

Below are the most recent publications written about "Pre-Exposure Prophylaxis" by people in Profiles.

Chai P, De D, Albrechta H, Goodman GR, Takabatake K, Ben-Arieh A, Lee JS, Glynn TR, Mayer K, O'Cleirigh C, Fisher C. Attitudes towards participating in research involving digital pill systems to measure oral HIV pre-exposure chemoprophylaxis: a cross-sectional study among men who have sex with men with substance use in the USA. BMJ Open. 2023 01 30; 13(1):e067549.

View in: PubMed
Goodman GR, Vaz C, Albrechta H, Boyer EW, Mayer KH, O'Cleirigh C, Chai PR. Ingestible Electronic Sensors for Monitoring Real-time Adherence to HIV Pre-exposure Prophylaxis and Antiretroviral Therapy. Curr HIV/AIDS Rep. 2022 10; 19(5):433-445.

View in: PubMed
Argenyi MS, Molotnikov LE, Leach DH, Roosevelt KA, Klevens RM, Hsu KK. Gaps in HIV Preexposure Prophylaxis Continuum of Care Following State Partner Services for Massachusetts Primary and Secondary Syphilis Cases, 2017 to 2018. Sex Transm Dis. 2022 09 01; 49(9):657-661.

View in: PubMed
Eshleman SH, Fogel JM, Piwowar-Manning E, Chau G, Cummings V, Agyei Y, Richardson P, Sullivan P, Haines CD, Bushman LR, Petropoulos C, Persaud D, Kofron R, Hendrix CW, Anderson PL, Farrior J, Mellors J, Adeyeye A, Rinehart A, St Clair M, Ford S, Rooney JF, Mathew CA, Hunidzarira P, Spooner E, Mpendo J, Nair G, Cohen MS, Hughes JP, Hosseinipour M, Hanscom B, Delany-Moretlwe S, Marzinke MA. Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084. J Infect Dis. 2022 05 16; 225(10):1741-1749.

View in: PubMed
Goodman GR, Kikut A, Bustamante MJ, Mendez L, Mohamed Y, Shachar C, Cohen IG, Gerke S, Boyer EW, Rosen RK, Mayer KH, O'Cleirigh C, Chai PR. "I'd feel like someone was watchin' me? watching for a good reason": perceptions of data privacy, access, and sharing in the context of real-time PrEP adherence monitoring among HIV-negative MSM with substance use. AIDS Behav. 2022 Sep; 26(9):2981-2993.

View in: PubMed
Chai PR, Mohamed Y, Bustamante MJ, Goodman GR, Najarro J, Castillo-Mancilla J, Baez A, Bronzi O, Sullivan MC, Pereira LM, Baumgartner SL, Carnes TC, Mayer KH, Rosen RK, Boyer EW, O'Cleirigh C. DigiPrEP: A Pilot Trial to Evaluate the Feasibility, Acceptability, and Accuracy of a Digital Pill System to Measure PrEP Adherence in Men Who Have Sex With Men Who Use Substances. J Acquir Immune Defic Syndr. 2022 02 01; 89(2):e5-e15.

View in: PubMed
Chai PR, Goodman GR, Bronzi O, Gonzales G, Baez A, Bustamante MJ, Najarro J, Mohamed Y, Sullivan MC, Mayer KH, Boyer EW, O'Cleirigh C, Rosen RK. Real-World User Experiences with a Digital Pill System to Measure PrEP Adherence: Perspectives from MSM with Substance Use. AIDS Behav. 2022 Jul; 26(7):2459-2468.

View in: PubMed
Hughes JP, Williamson BD, Krakauer C, Chau G, Ortiz B, Wakefield J, Hendrix C, Amico KR, Holtz TH, Bekker LG, Grant R. Combining information to estimate adherence in studies of pre-exposure prophylaxis for HIV prevention: Application to HPTN 067. Stat Med. 2022 03 15; 41(6):1120-1136.

View in: PubMed
Chai PR, Mohamed Y, Goodman G, Bustamante MJ, Sullivan MC, Najarro J, Mendez L, Mayer KH, Boyer EW, O'Cleirigh C, Rosen RK. Development of a digital pill and respondent behavioral intervention (PrEPSteps) for HIV pre-exposure prophylaxis adherence among stimulant using men who have sex with men. Transl Behav Med. 2022 01 18; 12(1).

View in: PubMed
Engelman KD, Engelman AN. Long-Acting Cabotegravir for HIV/AIDS Prophylaxis. Biochemistry. 2021 06 08; 60(22):1731-1740.

View in: PubMed

People

Explore

Similar Concepts

Top Journals